Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer

TY - JOUR

T1 - Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non‐Small Cell Lung Cancer

AU - Ahluwalia, Manmeet S.

AU - Becker, Kevin

AU - Levy, Benjamin P.

N1 - Central nervous system (CNS) metastases are a common complication in patients with epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC), resulting in a poor prognosis and limited treatment options. Treatment of CNS metastases requires a multidisciplinary approach, and the optimal treatment options and sequence of therapies are yet to be established.

PY - 2018/10/1

Y1 - 2018/10/1

UR - https://jhu.pure.elsevier.com/en/publications/epidermal-growth-factor-receptor-tyrosine-kinase-inhibitors-for-c

U2 - 10.1634/THEONCOLOGIST.2017-0572

DO - 10.1634/THEONCOLOGIST.2017-0572

M3 - Article

VL - 23

JO - Oncologist

JF - Oncologist

ER -